Dunne J A, Travers J P
Trans Ophthalmol Soc U K (1962). 1979;99(4):481-4.
The results are presented of a double-blind trial comparing the efficacy of betamethasone phosphate 0.1 per cent, clobetasone butyrate 0.1 per cent, and placebo in the treatment of acute unilateral non-granulomatous uveitis. The two steroids gave comparable results in improvement of the patients' symptoms, although betamethasone phosphate was significantly more effective than clobetasone butyrate in improving the ocular signs of uveitis. In comparing the placebo group of patients with those given topical steroids, the former group, though improving, appeared to lag behind by approximately 1 week. Four patients receiving placebo, however, had to be withdrawn because of worsening of the condition. Mild cases of anterior uveitis would probably resolve without using topical steroids.
本文呈现了一项双盲试验的结果,该试验比较了0.1%的磷酸倍他米松、0.1%的丁酸氯倍他松和安慰剂治疗急性单侧非肉芽肿性葡萄膜炎的疗效。两种类固醇在改善患者症状方面效果相当,尽管磷酸倍他米松在改善葡萄膜炎眼部体征方面明显比丁酸氯倍他松更有效。将接受安慰剂治疗的患者组与接受局部类固醇治疗的患者组进行比较,前一组虽然病情有所改善,但似乎落后约1周。然而,有4名接受安慰剂治疗的患者因病情恶化而不得不退出试验。轻度前葡萄膜炎病例可能无需使用局部类固醇即可自行缓解。